DIALYSIS · CCN 332565

DaVita Riverdale Dialysis Center

BRONX, NY 10463

DialysisProfitDaVita
$5.5M
TOTAL REVENUE
6.9%
OPERATING MARGIN
4 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$5.5M
Total costs
$5.1M
Operating income (rev − costs)
$379K
Operating margin
6.9%
Total charges
$5.4M
Total treatments
12,716
Dialysis stations
31

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.8142—
Fistula Rate
DFC_FISTULA_RATE
66.6104—
Five Star Rating
DFC_FIVE_STAR
4——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
2.4235—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
1——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
186.270—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.17——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
18104—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
18.9369—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
2579—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
3084—
Standardized ED Visits Ratio
DFC_SEDR
0.7620—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
48.617—